UMd. Medicine Receives NIH Grant
The National Institutes of Health has awarded a four-year, $3.7 million grant to researchers at the University of Maryland School of Medicine to develop a personalized medicine program to help doctors diagnose and treat monogenic diabetes — a form of diabetes caused by a mutation in a single gene. The study will evaluate methods to implement this program in various health-care settings, with an objective to develop a model that could also be applied to caring for patients with genetic variations of other common diseases.
“This research will enhance our ability to identify and properly diagnose individuals and families with specific inherited forms of diabetes, tailor treatment to their diagnosis and identify other family members at risk for developing diabetes,” said Dr. Toni I. Pollin, a University of Maryland genetics researcher and lead investigator on the study. “Correct and early diagnosis and treatment should improve blood-sugar control and decrease life-threatening complications.”